Self-association of monoclonal antibodies (mAbs) at high concentrations can result in developability challenges such as poor solubility, aggregation, opalescence and high viscosity. There is a significant unmet need for methods that can evaluate self-association propensities of concentrated mAbs at the earliest stages in antibody discovery to avoid downstream issues. We have previously developed a method (affinity-capture self-interaction nanoparticle spectroscopy, AC-SINS) that is capable of detecting weak antibody self-interactions using unusually dilute mAb solutions (tens of µg/ml). Here we optimize and implement this assay for characterization of unpurified and highly dilute mAbs directly in cell culture media. This assay was applied to screen 87 mAbs obtained via immunization. Our measurements reveal a wide range of self-associative propensities for mAbs that bind to the same antigen and which differ mainly in their complementarity-determining regions. The least associative mAbs identified by AC-SINS were confirmed to be highly soluble when purified and concentrated by three to five orders of magnitude. This approach represents a key advance in screening mAb variants using unpurified antibody samples, and it holds significant potential to both improve initial candidate selection as well as to guide protein engineering efforts to improve the properties of specific mAb candidates.
Introduction
The success of monoclonal antibodies (mAbs) as therapeutics is based on several of their unique and attractive attributes (Breedveld, 2000; Weiner, 2006; Reichert, 2008) . Antibodies typically display long circulation times (weeks), possess breakdown products (amino acids) that are non-toxic, recruit immune cells to enhance their activity and possess high specificity that typically results in low off-target effects. In addition, the availability of robust in vivo and in vitro antibody discovery methods ranging from immunization to phage display enables reliable identification of high-affinity antibodies specific for a wide range of targets (Sidhu, 2000; Lonberg, 2005; Chao et al., 2006; Bradbury et al., 2011; Chan et al., 2014; Georgiou et al., 2014) . Finally, the ease of using similar platform approaches for the expression and purification of diverse mAbs greatly simplifies their production (Kelley, 2007; Shukla et al., 2007; Shukla and Thommes, 2010) .
Nevertheless, a limitation of using mAbs as therapeutics is that large doses (hundreds of mgs) are generally required for therapeutic activity . For subcutaneous delivery, this typically requires mAbs to be formulated at high concentrations. At elevated concentrations, some mAbs display undesirable behavior, including aggregation, phase separation, opalescence and abnormally high viscosity (Liu et al., 2005; Harn et al., 2007; Kanai et al., 2008; Patel et al., 2009; Nishi et al., 2010; Salinas et al., 2010; Lowe et al., 2011; Connolly et al., 2012; Sule et al., 2012; Yadav et al., 2012; Alsenaidy et al., 2013; Cheng et al., 2013; Lee et al., 2013; Roberts et al., 2013; Li et al., 2014; Rakel et al., 2015) . Aggregation is especially concerning because protein aggregates may be immunogenic (Kumar et al., 2011; Singh, 2011; Brinks et al., 2011 Brinks et al., , 2013 Ratanji et al., 2014) , while high viscosity can frustrate effective antibody delivery through small bore needles (Shire et al., 2004; Dani et al., 2007; Jezek et al., 2011) .
To avoid these problems, it is desirable to select mAb candidates during early antibody discovery that possess high solubility and low viscosity at high concentrations (Jacobs et al., 2010; He et al., 2011; Samra and He, 2012; Xu et al., 2013; Yamniuk et al., 2013; Geng et al., 2014; Liu et al., 2014; Tessier et al., 2014) . This is challenging given the low purities and dilute concentrations of tens to thousands of mAb candidates typically available during antibody discovery. One approach is to use automated parallel expression and purification methods to generate purified and concentrated mAb samples for each candidate, and directly investigate their biophysical properties (Bannister et al., 2006; Jager et al., 2013; Barnard et al., 2014) . Strengths of this approach are that the properties of purified antibodies are directly examined at high concentrations, while weaknesses are that considerable resources are required to generate enough material for characterization and the feasibility of this approach decreases with increasing number of mAb candidates.
An attractive approach to this problem would be to evaluate the biophysical properties of mAb candidates prior to purification. Obvious challenges are the relatively low concentrations of antibodies obtained using standard expression systems, the small cell culture volumes compatible with high-throughput expression systems and the presence of cell-derived and media impurities that interfere with characterization of their biophysical properties. We posited that these challenges could be overcome (at least in part) by using nanoparticles that can both selectively capture dilute mAbs from unpurified solutions (i.e. cell culture supernatants) and report on the extent of mAb selfassociation. The rationale for measuring mAb self-interactions is that attractive self-interactions are generally correlated with increased viscosity and decreased solubility (Liu et al., 2005 (Liu et al., , 2014 Kanai et al., 2008; Nishi et al., 2010; Bethea et al., 2012; Connolly et al., 2012; Sule et al., 2012; Yadav et al., 2012; Sule et al., 2013; Li et al., 2014) .
Our approach (affinity-capture self-interaction nanoparticle spectroscopy, AC-SINS; Fig. 1 ) is to coat gold nanoparticles with capture (e.g. goat anti-human Fc) antibodies, and then use these conjugates to selectively bind human mAbs from dilute solutions (Sule et al., 2013) . The colloidal stability of the resulting conjugates is dependent on the propensity of the immobilized mAbs to self-associate, which can be monitored via the plasmon wavelength (wavelength of maximum absorbance). We find that attractive mAb self-interactions lead to redshifted plasmon wavelengths, while repulsive mAb self-interactions lead to either no change or blue-shifted plasmon wavelengths.
The ability of AC-SINS to evaluate mAb self-association using dilute and complex solutions suggests that it may be compatible with early antibody discovery. Indeed, we found previously that the unique propensities of closely related mAbs to self-associate could be detected via AC-SINS when purified mAbs were mixed with cell culture media (Sule et al., 2013) . Nevertheless, it is likely to be more difficult to characterize unpurified mAbs using AC-SINS due to antibody and non-antibody contaminants in cell culture supernatants. These contaminants may include incompletely assembled antibodies and other cell-derived contaminants such as DNA and host-cell proteins. Moreover, the robustness of AC-SINS to guide the discovery of new mAbs with superior biophysical properties prior to purification is unclear. Here we report the optimization and integration of AC-SINS into the discovery of new mAbs obtained via immunization. We critically evaluate the ability of AC-SINS measurements obtained prior to antibody purification to identify mAbs that are both highly and poorly soluble when purified and concentrated.
Experimental section

Materials
Citrate-stabilized gold nanoparticles (20 nm) were obtained from Ted Pella (15705; Redding, CA). Potassium acetate (P171), glacial acetic Fig. 1 Schematic depiction of AC-SINS. Goat anti-Fc antibodies are adsorbed on gold nanoparticles, and the conjugates are blocked with PEG containing a terminal thiol group (PEG-SH). After removal of most of the free anti-Fc IgG and PEG-SH, the conjugates are used to immobilize mAbs from highly dilute antibody solutions (<10 µg/ml mAb) such as unpurified cell culture supernatants. The propensity of immobilized mAbs to self-associate is detected via measurements of the plasmon wavelength (wavelength at maximum absorbance). Red-shifted plasmon wavelengths generally correspond to attractive self-interactions, while blue-shifted ones generally correspond to repulsive interactions. acid (AC12404) and sodium chloride (S271) were purchased from Thermo Fisher Scientific. Polyethylene glycol (PEG) methyl ether thiol (MW 2000; 729140) , sodium citrate (S1804), citric acid (251275) and sodium phosphate dibasic dihydrate (30435) were obtained from Sigma-Aldrich. Polyclonal goat non-specific antibody (005-000-003), polyclonal goat anti-human antibody (Fc fragment specific; 109-005-008) and polyclonal goat anti-rabbit antibody (Fc fragment specific; 111-005-008) were purchased from Jackson Immunoresearch.
Methods
Cloning CNTO607 and a point mutant (W100aA; Trp to Ala at position 100a in HCDR3) were created by gene synthesis (G-blocks, IDT) using published sequences (Teplyakov et al., 2009; Wu et al., 2010; Bethea et al., 2012) . The genes were cloned into a mammalian expression vector that provided the constant region of the lambda light chain or (on a separate plasmid) the IgG1 heavy chain using ligation independent cloning (Gibson Assembly, NEB). 405d is an IgG4 variant of an antibody with low self-associative behavior [mAb1 (Sule et al., 2013) ]. Rabbit mAb clones were obtained from an immunization campaign at Eli Lilly. All rabbit mAbs bound soluble antigen, were unique in variable domain sequences, and contained identical constant regions. Furthermore, the mAbs possessed divergent HCDR3 sequences, which indicates highly diverse binding modalities.
Transient expression mAbs were expressed transiently in HEK293F cells using Freestyle transfection reagents and protocols provided by the manufacturer (Life Technologies). Heavy and light chain genes were present on separate mammalian expression plasmids transfected at a 1:3 ratio, respectively. Transfected cells were grown at 37°C in a 5% CO 2 incubator while shaking at 125 rpm for 5 d. Secreted protein was harvested by centrifugation at 5000 rpm for 5 min, and the resulting supernatants were assayed as unpurified samples. Culture supernatants were clarified using 2 µm filters.
Gold nanoparticle immobilization
The suitability of gold nanoparticles for AC-SINS was evaluated by filtering a fixed volume of undiluted colloid (4 ml) using a 0.22 µM filter (PVDF, 13 mm, Merck Millipore, SLVG013SL), and evaluating the fractional recovery of the colloid. The capture antibody (antihuman or anti-rabbit, Fc specific) was buffer exchanged twice into 20 mM potassium acetate ( pH 4.3) using 7 kDa MWCO Zeba spin desalting columns (Thermo Fisher Scientific, PI-89882) and then filtered with 0.22 µm PVDF syringe filters (4 mm, Merck Millipore, SLGV004SL). The antibody concentration was determined by absorbance measurements at 280 nm using extinction coefficients of 1.2 ml/ (mg·cm) and 1.3 ml/(mg·cm) for anti-human and anti-rabbit capture antibodies, respectively. The capture antibody solution was subsequently diluted to 0.4 mg/ml using 20 mM acetate ( pH 4.3). One part of the capture antibody was mixed with nine parts of 20 nm gold nanoparticles, the latter of which was initially diluted with water to 0.67× of the stock gold solution (4.67 × 10 11 particles/ml after dilution). The mixture was incubated overnight in 1.7 ml polypropylene microcentrifuge tubes (VWR, at room temperature. Afterward, 1 µM of thiolated PEG was added to the gold-antibody conjugates (final concentration of 0.1 µM PEG) to prevent non-specific interactions, and the mixture was incubated for 1 h.
The conjugates were then sedimented in the polypropylene microcentrifuge tubes for 6 min at 15 000 rpm, after which ∼95% of the supernatant volume was removed. The remaining ∼5% of the pelleted solution was resuspended and diluted 10-fold in 2 mM acetate ( pH 4.3).
mAb immobilization and plasmon wavelength measurements
For experiments performed with 10 mM sodium citrate and 50 mM NaCl ( pH 6), polyclonal goat non-specific antibody (∼2.7 mg/ml) was buffer exchanged twice into citrate buffer (11.1 mM sodium citrate, 58.5 mM NaCl, pH 6) and filtered. For other solution conditions, the goat non-specific antibody was buffer exchanged into citrate buffer without salt (11.1 mM sodium citrate, pH 6), citrate buffer with high salt (11.1 mM sodium citrate, 175 mM NaCl, pH 6) or PBS (11.1 mM sodium phosphate, 175 mM NaCl, pH 7.4). The antibody concentration was calculated by measuring the absorbance at 280 nm using an extinction coefficient of 1.3 ml/(mg·cm). The goat non-specific antibody was then diluted to 117 µg/ml in the corresponding buffer solution that was used during buffer exchange. For purified human or rabbit antibodies, the stock mAb solution was diluted in citrate buffer (0 mM NaCl, pH 6) to 22 µg/ml. Afterward, one part of human or rabbit antibody solution (22 µg/ml) was mixed with 19 parts of goat non-specific antibody solution (117 µg/ml) in citrate buffer to obtain 1.11 µg/ml mAb, 111 µg/ml non-specific goat antibody, 55.6 mM NaCl and 11.1 mM citrate ( pH 6). For unpurified human or rabbit antibodies, the stock mAb solution was diluted with clarified cell culture media (instead of citrate buffer) to 22 µg/ml mAb (corresponding to a citrate concentration of 10.5 mM). Subsequently, one part of the unpurified antibody solution was mixed with 19 parts of the goat non-specific antibody solution in the corresponding buffer used for the purified mAbs, resulting in a solution with 5% media. Finally, one part of the capture conjugates was mixed with nine parts of the final mAb solution (which contained 111 µg/ml of goat non-specific antibody) in 384-well transparent polystyrene plates (Thermo Fisher Scientific, 12565506) with a final volume of 80 µl. The final solution condition for the purified mAbs at 50 mM NaCl was 10 mM sodium citrate, pH 6 and 1 µg/ml mAb. The corresponding final solution condition for the unpurified mAbs at 50 mM NaCl was 9.5 mM sodium citrate, pH 6, 1 µg/ml mAb and 4.5% media. Other solution conditions that were evaluated using different buffers and/or salt concentrations were prepared accordingly. After incubating for 2 h, the absorbance spectra (450-650 nm) were measured using a Tecan Safire 2 plate reader (20 reads per well, 1 nm wavelength intervals). The plasmon wavelength for each sample was determined by fitting second-order polynomial functions over 60 data points (510-570 nm) and calculating the wavelength of the maximum absorbance using a quadratic function.
Scale-up of antibody expression and purification After HEK293F transient expression at 1 L scale, harvested media was clarified and loaded onto a 5 ml HiTrap rProtein A FF column (GE Healthcare, 17-5080-02) equilibrated with 1× PBS. The column was washed with 1× PBS and protein was eluted using 10 mM sodium citrate ( pH 2.5) and neutralized by adding 1M Tris (10% of final volume, pH 8.0). The neutralized fractions were then pooled, filtered and injected onto a Superdex 200 26/60 preparative SEC column (Amersham Biosciences, 17-1071-01) equilibrated with 1× PBS. After isocratic flow for two column volumes of 1× PBS, the main peak fractions were identified and pooled for analysis.
Dynamic light scattering (DLS)
The DLS measurements of the gold particles and anti-Fc antibody were performed using a DynaPro Titan light scattering system (Wyatt, Santa Barbara, CA, USA). The gold nanoparticles were used after mixing two parts of gold solution with one part of water. Afterward, nine parts of the gold colloid was mixed with one part of water, acetate buffer (20 mM, pH 4.3) or anti-Fc antibody (0.4 mg/ml, 20 mM acetate, pH 4.3). After 1 h of incubation, the samples (0.1 ml) were transferred to disposable cuvettes (Eppendorf, 952010069) and evaluated. The scattering data were fit (Dynamics software; Wyatt) assuming the scatterers to be Rayleigh spheres. The measurements of diffusion interaction parameters were conducted at 25 ± 0.1°C using a DynaPro Plate Reader (Wyatt). The buffer conditions were 10 mM citrate at pH 6 with and without 150 mM NaCl. The buffers were filtered through sterile 0.22 µm nitrocellulose membrane filters (Millipore, SCGPU11RE) before dialysis (Slide-A-Lyzer dialysis cassette G2, 10 kDa MWCO; Thermo Scientific, 87730). After dialysis, the concentration of IgG in the solution was adjusted to 12 mg/ml and the pH was checked to ensure consistency. The protein solutions were then sedimented at 10 000 × g for 10 min before analysis. The sample volume used for analysis was 60 µl. Twenty microliters of each sample were dispensed into a low volume 384-well polystyrene plate (3540, Corning) in triplicate and topped with mineral oil. A total of 10 scans, each with duration of 15 s, were run for each sample. Samples were analyzed at 2, 4, 6, 8, 10 and 12 mg/ml for each solution condition.
Solubility analysis
To characterize the solubility of purified rabbit mAbs, 3-5 mg of each antibody at 1 mg/ml was added to 30 kDa MWCO Vivaspin 2 centrifugal concentrators (Sartorius Stedim Biotech, VS0222) in volumes of ∼2.5 ml and centrifuged at 4000 × g (4°C). The volumes were periodically checked and protein was added to the concentrators until the remaining protein solutions had been consumed. Concentration proceeded for 2 h until either the volume reached ∼20 µl or stopped decreasing. Material was recovered by centrifuging the inverted filter unit into a pre-weighed tube. The recovered volume was determined by re-weighing the tube after recovery of the concentrated protein.
The concentration was determined by performing UV measurements of samples obtained by diluting 1 µl of concentrated mAb into 199 µl of each respective buffer. The samples were evaluated for aggregation using analytical SEC after diluting mAbs to 1 mg/ml in their respective buffers. The concentrated proteins were also examined visually for phase separation after 2 d at 4°C.
Results
Optimization of AC-SINS for screening unpurified mAbs
As a first step toward optimizing our assay for analyzing mAbs in unpurified samples, we sought to establish standards by which to judge the suitability of gold nanoparticles for our assay given the high sensitivity of such non-derivatized colloids to changes in solution environment (e.g. ionic strength) and/or temperature. The pH of the stock gold (as judged by pH paper) was typically pH 5.0-5.3. However, we occasionally identified batches of gold that displayed slightly higher initial pH values (∼5.3-5.8). DLS analysis of both types of gold solutions revealed particle sizes (diameters of 20-26 nm), which were generally consistent with the expected size (20 nm; Supplementary Fig. S1 ). Moreover, the plasmon wavelengths of both types of gold solutions were similar (523-524 nm). However, filtration of the non-derivatized colloids revealed significant differences (Supplementary Fig. S1 ). The particles with lower pH showed excellent filtration properties, as they could be easily filtered through 0.22 µm PVDF filters (diameter of 13 mm) with >95% recovery (4 ml filtered). In contrast, the particles with modestly higher pH displayed poor filtration properties and displayed reduced recovery (<80% for the same filtration volume). The latter particles were incompatible with our AC-SINS assay, as they aggregated when mixed with goat anti-human Fc antibody even when the gold was pre-filtered ( Supplementary Fig. S1 ) or its pH was lowered (data not shown). Therefore, we excluded these suboptimal batches of gold particles from AC-SINS experiments due to their low stability.
We also evaluated the stability of the anti-Fc conjugates as a function of the concentration of the capture antibody in the initial adsorption step (Supplementary Fig. S2 ). Importantly, low anti-Fc antibody concentrations (2.5 and 5 µg/ml) resulted in unstable conjugates, as evidenced visually by a pink-to-gray (2.5 µg/ml anti-Fc antibody) or pink-to-purple (5 µg/ml anti-Fc antibody) color change. The corresponding plasmon wavelengths for these conjugates (∼588 and ∼541 nm for 2.5 µg/ml and 5 µg/ml anti-Fc antibody, respectively) were also much higher than values reported for stable antibody-gold conjugates (529-530 nm) (Sule et al., 2011 (Sule et al., , 2013 . Higher concentrations of anti-Fc antibody (20-160 µg/ml) resulted in more stable conjugates that retained the pink color of the non-derivatized gold colloid and displayed lower plasmon wavelengths (529-531 nm) consistent with stable antibody-gold conjugates. Moreover, sedimentation of the conjugates with intermediate concentrations of anti-Fc antibody (5 and 10 µg/ml) led to significant adsorption of the conjugates on the walls of the microcentrifuge tubes. This problem was similar for multiple types of microcentrifuge tubes, including low-retention ones (Fisherbrand siliconized low-retention microcentrifuge tubes, 02-681-320; data not shown). However, higher anti-Fc antibody concentrations (20-160 µg/ml) reduced adsorption during sedimentation and improved recovery of antibody-gold conjugates ( Supplementary  Fig. S2 ). Therefore, we selected a concentration of 40 µg/ml of anti-Fc antibody during the initial adsorption step for high stability and recovery of the anti-Fc gold conjugates.
Next, we sought to optimize AC-SINS to maximize sensitivity for discriminating between antibody variants in unpurified solutions. Therefore, we initially used three human mAbs with known selfassociation properties. CNTO607 is a mAb isolated from a phage display library that is poorly soluble and abnormally viscous Bethea et al., 2012) , while a variant that only differs by a single amino acid in HCDR3 (W100aA) displays improved biophysical properties and an intermediate level of self-association Bethea et al., 2012) . As a control, we used a well-behaved Lilly mAb (405d) that displays little self-association.
To test the influence of clarified cell culture media on AC-SINS measurements, we compared the spectra for antibody-gold conjugates with 1 µg/ml of purified human mAb diluted in 5% media relative to the same mAbs diluted in buffer (10 mM citrate, pH 6, 50 mM NaCl; Fig. 2 ). As expected, CNTO607 showed the highest plasmon wavelength (545 nm) in the absence of media, while W100aA displayed an intermediate plasmon wavelength (538 nm). These findings are consistent with the increase in solubility and decrease in highconcentration viscosity reported previously for W100aA relative to CNTO607 Bethea et al., 2012) . We additionally confirmed that switching the isotype of CNTO607 from IgG1 to IgG4 also reduced self-association as judged by AC-SINS (data not shown), a result consistent with the reported impact of isotype switching for CNTO607 on solubility and viscosity Bethea et al., 2012) . 405d displayed a relatively low plasmon wavelength (531 nm) that is similar to the control without mAb (530 nm). The effect of media (5%) was a reduction in the plasmon wavelengths by 3-5 nm (Fig. 2) . Since the impact of media on the plasmon wavelength measurements was similar across all samples, AC-SINS appears to be compatible with measurements performed in the presence of low concentrations of media.
To further determine if AC-SINS is compatible with screening unpurified mAbs, we performed measurements using mAbs secreted from transiently transfected HEK293F cells without purification. For comparison, we performed measurements using purified mAbs in buffer and in media from a mock transfection. As before, mAbs were diluted to 1 µg/ml (∼10 mM citrate, pH 6, 50 mM NaCl) and the final media concentration (when present) was ∼5%. We observed good discrimination between the three mAbs, and this was weakly impacted by the media (∼5%) or the presence of impurities (Fig. 3A) . These results were also highly reproducible (Supplementary Fig. S3 ). However, we found that the sensitivity was modulated by the solution environment. For example, a similar condition without salt (pH 6, 10 mM citrate) resulted in inconsistent measurements between the samples with and without media (Fig. 3B) . The effect of media in the absence of salt was to reduce the magnitude of the plasmon wavelength shift. Measurements in PBS (pH 7.4) with 150 mM NaCl are similar for unpurified and purified samples, although this condition fails to discriminate between W100aA and 405d (Fig. 3C) . Moreover, we find that solutions at pH 6 (10 mM citrate) with intermediate salt concentrations (25, 75 and 100 mM NaCl) also give strong discrimination between the three human mAbs (Supplementary Fig. S4 ), as observed at 50 mM NaCl (Fig. 3A) . These results suggest that some salt is needed to reduce the impact of impurities on the assay. An intermediate salt concentration (50 mM NaCl) at pH 6 (10 mM citrate) was chosen as a useful screening Fig. 3 Effect of solution conditions on the plasmon wavelength measurements for purified and unpurified human antibodies. Gold nanoparticles were coated with goat anti-human Fc antibody and incubated in the absence (control) and presence of human mAbs. The experiments were performed using (A) 10 mM sodium citrate and 50 mM NaCl at pH 6, (B) 10 mM citrate at pH 6 and (C) 10 mM phosphate and 150 mM NaCl (PBS) at pH 7.4. Goat non-specific antibody at 100 µg/ml (final concentration) was added to all samples. The final concentrations of the mAbs, citrate and media were 1 µg/ml, 10 mM (for samples without media) or 9.5 mM (for samples with media), and 4.5%, respectively. The data are average plasmon shifts (Δλ p ) of three replicates calculated by subtracting the plasmon wavelengths for each sample from the corresponding control without mAb, and the error bars are the corresponding standard deviations. Fig. 2 Absorbance spectra of antibody-gold conjugates incubated with human antibodies that have different propensities to self-associate. The spectra for gold nanoparticles (20 nm) coated with goat anti-human Fc antibody in the absence (control) and presence of human mAbs (405d, W100aA, CNTO607). The purified mAbs (1 µg/ml) were immobilized at pH 6 (10 mM sodium citrate, 50 mM NaCl, 100 µg/ml goat non-specific antibody) in the absence (open symbols) or presence (closed symbols) of 5% cell culture media. For samples with media, the final concentrations of citrate and media were 9.5 mM and 4.5%, respectively, due to dilution. The arrows indicate the plasmon wavelengths for each condition. The spectra are shifted vertically for clarity.
condition for discriminating between mAbs with different propensities to self-associate.
We also suspected that the mAb concentration would affect the sensitivity of AC-SINS because subsaturating antibody concentrations can lead to cross-capture of mAbs by multiple particles (increased plasmon shifts) or loss of signal (reduced plasmon shifts). Therefore, we evaluated the assay for the three mAbs at a range of antibody concentrations (0.0625, 0.25, 1 and 4 µg/ml) at pH 6 (10 mM citrate and 50 mM NaCl; Fig. 4) . The sensitivity of the assay was similar at 0.25, 1 and 4 µg/ml, suggesting that these antibody concentrations did not lead to affinity cross-capture or loss of signal. However, the lowest mAb concentration (0.0625 µg/ml) led to variable results that were different from those at higher concentration and which failed to indicate the correct ranking of self-association for the purified samples. These findings suggest that the use of 1 µg/ml mAb is optimal because a 4-fold increase or decrease in mAb concentration weakly impacted the results. At this mAb concentration, we also confirmed that increasing the amount of residual media from 5 to 25% weakly impacted the results, although the results for purified and unpurified samples are more similar at 5% media ( Supplementary Fig. S5 ). Therefore, we conclude (based on our limited analysis) that the optimal assay conditions for differentiating the self-association behavior of mAbs are buffered solutions ( pH 6, 10 mM citrate) containing ∼50 mM NaCl, 1 µg/ml mAb and 5% media.
Screening unpurified rabbit mAbs using AC-SINS
We next applied our optimized assay to screen a panel of antibodies obtained from a discovery campaign at Eli Lilly in which rabbits were immunized with a soluble antigen. One hundred and forty unique mAbs with binding activity were transiently expressed in HEK293F cells at 1 ml scale in the 96-well format. The mAb concentrations in the cell culture supernatants ranged from 1 to 200 µg/ml. mAbs that expressed lower than ∼20 µg/ml were eliminated, which resulted in 87 mAbs that were further analyzed. Mock transfected cultures were included to provide media for standardizing mAb concentrations to 1 µg/ml and 5% media.
We performed AC-SINS with an anti-rabbit Fc capture antibody to evaluate mAb self-association using the unpurified cell culture supernatants (Fig. 5) . Optimized solution conditions were used (1 µg/ml mAb, ∼5% media, ∼10 mM citrate, pH 6, 50 mM NaCl). Interestingly, we obtained a wide range of plasmon shifts, indicating that mAbs obtained Fig. 4 Effect of mAb concentration on plasmon wavelength measurements for purified and unpurified human antibodies. Gold nanoparticles coated with goat anti-human Fc antibody were incubated with human mAbs and assayed using the same condition as described in Fig. 3A ( pH 6, 50 mM NaCl). The mAbs were evaluated at final concentrations of (A) 0.0625 µg/ml (B) 0.25 µg/ml (C) 1 µg/ml and (D) 4 µg/ml. Goat non-specific antibody (100 µg/ml final concentration) was added to all conditions, and the final buffer and media concentrations were 9.5 mM citrate and 4.5% for samples with media, and 10 mM citrate for samples without media. The data are average plasmon shifts (Δλ p ) of three replicates calculated by subtracting the plasmon wavelengths for each sample from the corresponding control without mAb, and the error bars are the corresponding standard deviations. via immunization possess variable propensities to self-associate. We confirmed for a subset of the mAbs that the results were consistent for different transfections (Supplementary Fig. S6 ). This suggests that our assay is weakly impacted by differences that may result from different mAb transfections.
AC-SINS analysis of a subset of purified rabbit mAbs
Next, 12 mAbs that possess a range of self-association behaviors were selected for purification and further analysis. Seven of these mAbs (2B7, 1F2, 1C1, 1A7, 1C3, 1G2 and 2G8) displayed relatively small plasmon shifts (<1 nm), while five (1F7, 1B10, 1H5, 1H9 and 1B5) displayed elevated plasmon shifts (>2 nm). We evaluated the self-association behavior of the rabbit mAbs at pH 6 (10 mM citrate) with 0, 50 and 150 mM NaCl to sample solution environments related to those used for screening (Fig. 6) . The results at 0 mM NaCl demonstrate a significant difference between the self-association behavior of the two groups of mAbs (Fig. 6A) , consistent with our predictions based on measurements of these mAbs using unpurified solutions (Fig. 5) . The results are similar at an intermediate salt concentration (50 mM NaCl), although there is some segregation between mAbs with moderate (1F7, 1B10 and 1H5) and high (1H9 and 1B5) propensities to self-associate (Fig. 6B) . Importantly, this segregation is consistent with the initial plasmon wavelength measurements for unpurified mAbs (Fig. 5) . Moreover, the results at high salt (150 mM NaCl) show further reduction in the self-association propensities of 1F7, 1B10 and 1H5 relative to 1H9 and 1B5 (Fig. 6C) . Importantly, the latter two mAbs displayed the highest propensities to self-associate (of the 12 selected mAbs) in the initial screen using unpurified antibodies (Fig. 5) .
Comparison of AC-SINS results to solubility and light scattering measurements
We next analyzed the solubility of the 12 mAbs selected from the AC-SINS screen (Fig. 7) . Antibody solubility was evaluated using an ultracentrifugation assay and reported as the maximum mAb concentration that could be achieved in a specific formulation. In the absence of salt (10 mM citrate, pH 6), the seven mAbs identified by AC-SINS to be weakly self-associative showed solubilities >50 mg/ml, while those identified to be moderately or highly self-associative showed solubilities <20 mg/ml (Fig. 7A) . Three of the five poorly soluble mAbs (1F7, 1H9 and 1B5) showed visible precipitation, while none of the well-behaved mAbs displayed precipitation (Supplementary Table SI) . At higher salt concentrations (50 and 150 mM NaCl), mAb solubility generally increased and the solubility differences for mAbs with low and high selfassociation propensities were reduced (Fig. 7B and C) . These findings are consistent with the reduced differences in plasmon wavelengths observed for the same mAbs at 150 mM NaCl with the exception of two mAbs (1H9 and 1B5; Fig. 6 ). Notably, these two mAbs that showed the greatest plasmon shifts in the initial screen are the two least soluble ones at 150 mM NaCl (Fig. 7C ). These results demonstrate that AC-SINS measurements of dilute, unpurified mAbs correlate with solubility measurements of purified mAbs at much higher concentrations.
While the correlation of AC-SINS and solubility measurements was the primary goal of this investigation, we also sought to compare plasmon wavelength measurements directly to an established method for measuring protein-protein interactions. DLS is a useful method for assessing thermodynamic and hydrodynamic interactions of antibody solutions (Some, 2013) . The diffusion interaction parameter-which can be obtained from measurements of the diffusion coefficient as a function of antibody concentration-has been correlated with thermodynamic measures of antibody self-association such as the second virial coefficient (Lehermayr et al., 2011; Connolly et al., 2012; Saito et al., 2012) . Therefore, we measured diffusion coefficients for each mAb as a function of antibody concentration to obtain the corresponding diffusion interaction parameters (k D ; Fig. 8 ). Large negative values of k D are generally correlated with attractive mAb self-interactions (Lehermayr et al., 2011; Connolly et al., 2012; Fig. 5 Plasmon wavelength measurements for a library of unpurified rabbit mAbs. Gold nanoparticles were coated with goat anti-rabbit Fc antibody and incubated in the absence (control) and presence of 87 unpurified rabbit mAbs. Each individual mAb was assayed at 1 µg/ml (final concentration), pH 6 (9.5 mM citrate, 50 mM NaCl), 100 µg/ml of goat non-specific antibody and 4.5% media. The data are average plasmon shifts (Δλ p ) of three replicates calculated by subtracting the plasmon wavelengths for each sample from the corresponding control without mAb, and the error bars are the corresponding standard deviations. The lines indicate 12 select mAbs with Δλ p values < 1 nm (2B7, 1F2, 1C1, 1A7, 1C3, 1G2 and 2G8) and >2 nm (1F7, 1B10, 1H5, 1H9 and 1B5). Fig. 7 Evaluation of the solubility of purified rabbit mAbs using an ultracentrifugal filtration assay. Each rabbit mAb (3-5 mg/ml initial concentration) was prepared at pH 6 (10 mM citrate) with (A) 0 mM NaCl, (B) 50 mM NaCl and (C) 150 mM NaCl, and concentrated using 30 kDa filters. The final antibody concentration of the retentate was evaluated using UV absorbance measurements. The mAbs ( prior to purification) with Δλ p values of <1 nm in Fig. 5 (2B7, 1F2, 1C1 , 1A7, 1C3, 1G2 and 2G8) are indicated with gray bars, while those with Δλ p values >2 nm (1F7, 1B10, 1H5, 1H9 and 1B5) are indicated with black bars. Fig. 6 Evaluation of plasmon wavelengths for purified rabbit mAbs. Gold nanoparticles were coated with goat anti-rabbit Fc antibody and incubated in the absence (control) and presence of purified rabbit mAbs. Each mAb was assayed at 1 µg/ml (final concentration) at pH 6 (10 mM citrate) with (A) 0 mM NaCl, (B) 50 mM NaCl and (C) 150 mM NaCl. Goat non-specific antibody (100 µg/ml final concentration) was added to each sample. The data are average plasmon shifts (Δλ p ) of three replicates calculated by subtracting the plasmon wavelengths for each sample from the corresponding control without mAb, and the error bars are the corresponding standard deviations. The mAbs ( prior to purification) with Δλ p values of < 1 nm in Fig. 5 (2B7, 1F2,  1C1 , 1A7, 1C3, 1G2 and 2G8) are indicated with gray bars, while those with Δλ p values >2 nm (1F7, 1B10, 1H5, 1H9 and 1B5) are indicated with black bars. Saito et al., 2012) , although k D also contains hydrodynamic contributions and must be interpreted carefully (Saluja et al., 2010) . Importantly, the k D values for the five mAbs (1F7, 1B10, 1H5, 1H9, 1B5) identified by AC-SINS to be most associative were more negative (or could not be measured due to precipitation for 1F7 at 0 M NaCl) than the seven mAbs predicted to be well behaved both at 0 mM NaCl (Fig. 8A ) and 150 mM NaCl (Fig. 8B) .
The AC-SINS and other biophysical (solubility and diffusion interaction parameter) measurements are summarized in Table I . The overall data show significant but imperfect segregation between the top seven mAbs initially selected with low self-association and the bottom five mAbs selected with enhanced self-association. At low ionic strength, there is good correspondence between the AC-SINS measurements (unpurified and purified at 0 mM NaCl) with both high solubility and low self-association. At higher ionic strength (50 and 150 mM NaCl), this correspondence is generally maintained, but there are exceptions. For example, the mAbs 1F7, 1B10, 1H5 and 1H9 display solubilities ≥100 mg/ml at 150 mM NaCl despite that their plasmon shifts are 1.8-13 nm and their k D values are −13 to −18 ml/g. Nevertheless, the six mAbs identified with negative plasmon shifts during the screening stage using unpurified solutions are generally the most soluble and least associative ones, demonstrating the utility of AC-SINS for identifying highly soluble antibodies.
Discussion
We have evaluated the feasibility of using measurements of mAb selfassociation prior to antibody purification to guide the selection of mAbs with high solubility. One of the most challenging aspects of this study was the identification of suitable solution conditions for performing our screen using unpurified and highly dilute samples. Initially, we evaluated two conditions-one at pH 6 without salt (10 mM citrate) and the other at pH 7.4 with salt (10 mM phosphate, Fig. 8 Evaluation of purified rabbit mAbs using DLS. Each rabbit mAb was concentrated at pH 6 (10 mM citrate) with (A) 0 mM NaCl and (B) 150 mM NaCl. The mAbs were diluted in the corresponding citrate buffer to concentrations of 2-12 mg/ml and analyzed by DLS to calculate the diffusion interaction parameter (k D ). The mAb 1F7 precipitated when concentrated in absence of NaCl and could not be analyzed via light scattering. The mAbs ( prior to purification) with Δλ p values of <1 nm in Fig. 5 (2B7, 1F2, 1C1 , 1A7, 1C3, 1G2 and 2G8) are indicated with gray bars, while those with Δλ p values >2 nm (1F7, 1B10, 1H5, 1H9 and 1B5) are indicated with black bars. The standard error was calculated from a linear regression of the diffusion coefficients as a function of the mAb concentration. Table I . Summary of AC-SINS and biophysical analysis for select rabbit mAbs The results are for ultracentrifugal filtration (solubility), DLS (diffusion interaction parameter, k D ) and AC-SINS ( plasmon shift, Δλ p ). The experiments were performed at pH 6 with ∼10 mM citrate and different concentrations of sodium chloride.
150 mM NaCl)-and neither was suitable for differentiating between the three human mAbs that we used to calibrate our assay. This was particularly clear for the pH 6 condition (10 mM citrate) when we compared purified samples without media to either purified or unpurified samples with media (Fig. 3B) . It may be that the low ionic strength environment favors interactions between components in the media and the gold conjugates such that mAb self-association is masked. Conversely, we find that an increased salt concentration (150 mM NaCl, PBS) leads to robust discrimination between CNTO607 and its more soluble mutant (W100aA), but this condition eliminates discrimination between 405d and W100aA (Fig. 3C ). It may be that an important difference between 405d and W100aA self-association is the contribution of electrostatic interactions, which are masked at high salt concentrations (150 mM NaCl). Moreover, previous studies have shown that CNTO607 self-association is mediated by hydrophobic interactions involving a triad of aromatic residues in HCDR3 Bethea et al., 2012) , and it is logical that these interactions are impacted weakly by the addition of salt.
The solution condition we identified that was optimal for differentiating between the three human mAbs ( pH 6, 10 mM citrate, 50 mM NaCl) appears to reduce interference from the media observed in the absence of salt without strongly dampening electrostatic interactions. We confirmed that closely related salt concentrations (25-100 mM NaCl) at pH 6 give similar results ( Supplementary Fig. S4 ), and expect that other suitable conditions could be readily identified with similar pH and ionic strength values. The significant throughput and low material consumption afforded by AC-SINS permits parallel screening at different pH and buffer compositions to broaden biophysical profiling of antibody variants.
We also found that parameters other than the solution environment influenced the sensitivity of our assay. For example, the amount of residual media in the unpurified samples generally reduces sensitivity, and there are several key points related to media concentration that deserve further consideration. First, the extent of dilution of the media in AC-SINS measurements is determined by the antibody concentration in the cell culture samples. Our optimized assay condition was ∼5% media, which required mAb supernatant concentrations of at least ∼20 µg/ml. A wide range of concentrations from heterologous expression of novel mAbs is common. The major contributor to expression variability is the antibody sequence itself. If sufficient numbers of antibodies with desired binding properties are available in the discovery pool, then it becomes expedient to eliminate low expressing antibodies from further consideration. However, cell culture supernatant concentrations as low as 5 µg/ml can be utilized if the final media concentration is increased to 25% (Supplementary Fig. S5 ), although the signal is somewhat compromised.
Another alternative for low titer samples is Protein A purification, which serves to increase mAb concentrations and is also compatible with automation. Filtration can be used to further concentrate Protein A purified material for AC-SINS measurements, but this approach is incompatible with unpurified mAbs because impurities that interfere with the assay are also concentrated. While we recommend dilution of the antibodies to a standard supernatant concentration of ∼20 µg/ml (∼1 µg/ml mAb and ∼5% media final concentrations after dilution), the assay is tolerant to differences in concentration. At a final mAb concentration of 1 µg/ml, the capture antibodies are saturated and 4-fold higher (or lower) mAb concentration did not appreciably impact the results (Fig. 4) . This quality improves the robustness of the assay.
We spent significant effort identifying weak points of our assay to anticipate problems others may have using this approach. Some users of our previous AC-SINS assay (Sule et al., 2013) find that the initial adsorption of anti-Fc polyclonal antibody leads to an immediate color change of the gold conjugates (red to blue transition). We observed the same problem occasionally and found that it is linked to problems with the gold colloid itself (Supplementary Fig. S1 ). While problematic batches of gold did not contain a significant amount of aggregate detectable by DLS, the pH of these colloidal solutions was slightly higher (pH ∼5.3-5.8) than for well-behaved batches of gold colloid ( pH of ∼5.0-5.3). These pH differences may indicate subtle differences in the particle synthesis, which could result in differences in the surface properties of the particles that impact adsorption of the anti-Fc antibody.
Nevertheless, the most robust method for identifying suitable batches of gold for our assay was not measurements of pH but rather measurements of particle recovery after filtration. Batches of gold that were incompatible with our assay fouled the filters and required significant force to filter them. This effect was exaggerated as the filtration volumes were increased (data not shown). We find that filtering 4 ml of gold through small PVDF filters (13 mm in diameter) with a moderate pore size (0.22 µm) is sufficient to easily identify batches of gold suitable for our assay (Supplementary Fig. S1 ). We recommend only gold particles that show the expected size by DLS, and which can be filtered and recovered at >95% using our procedures be used for AC-SINS experiments.
We also find that the colloidal stability of the initial conjugates coated with capture antibody (anti-Fc polyclonal) is strongly influenced by the concentration of capture antibody used in the immobilization step (Supplementary Fig. S2 ). In this report, we used 40 µg/ml of capture antibody for coating the particles, which typically prevented aggregation of the conjugates prior to mAb adsorption. However, we observed aggregation of the conjugates when the coating concentrations were reduced to 2.5 or 5 µg/ml. These findings are consistent with particle bridging at subsaturating antibody concentrations (Ho et al., 2014) . Much of the previous work in the immunohistochemistry field has demonstrated that stabilizing concentrations of antibodies can be reliably identified by varying the antibody concentration used for coating gold particles, and evaluating the minimum concentration that prevents particle aggregation upon the addition of salt (Faulk and Taylor, 1971; Geoghegan and Ackerman, 1977) . Thus, we suggest that a range of anti-Fc polyclonal antibody concentrations be evaluated (including concentrations higher than those used in this study) if particle aggregation is detected.
Another related problem that some users have experienced is that the polyclonal antibody-gold conjugates stick to the walls of microcentrifuge tubes after sedimentation and/or are difficult to resuspend after the sedimentation step that is required to remove unbound anti-Fc capture antibody. We also observed this problem at low polyclonal antibody concentrations (≤10 µg/ml; Supplementary Fig. S2 ), which could be overcome by increasing the concentration of anti-Fc antibody (20-160 µg/ml). Therefore, we suggest that higher anti-Fc polyclonal antibody concentrations be evaluated if problems arise during sedimentation and/or resuspension.
It was not clear that our limited studies for three human mAbs would lead to assay conditions that are useful for screening a large panel of rabbit mAbs. Nevertheless, we used identical conditions for both human and rabbit antibodies (except for a different speciesspecific anti-Fc capture antibody), and obtained a wide range of plasmon wavelength measurements for both types of antibodies. The range of plasmon shifts we observed for the unpurified rabbit mAbs (−3.3 to 16.4 nm) was similar to the range that we observed for the three unpurified human mAbs (0.9 to 13.4 nm) in the same solution environment. This suggested that the rabbit antibody library we generated contained mAbs with both low and high propensities to self-associate, and analysis of a subset of purified rabbit antibodies selected based on our AC-SINS studies verified this behavior.
The wide range of self-association behaviors of the mAbs generated in this study deserves further consideration. Conventional wisdom suggests that immunization leads to production of antibodies with desirable biophysical properties (i.e. high solubility and folding stability) due to natural filtering mechanisms in the antibody generation process. Indeed, previous studies have reported biophysical analysis of a similar size library of antibodies (92 mAbs) obtained from murine hybridomas (Spencer et al., 2012) . Interestingly, all such mAbs show low propensity to associate in PBS ( pH 7.4) with murine polyclonal antibodies using cross-interaction chromatography, which has been used as a surrogate measure of antibody solubility (Jacobs et al., 2010) . Notably, we also observed high solubility (≥100 mg/ ml) for most of the 12 selected rabbit mAbs (with the exception of 1B5) at a closely related solution condition ( pH 6, 10 mM citrate, 150 mM NaCl). However, some of the rabbit mAbs that were highly soluble at high ionic strength were poorly soluble at low ionic strength (such as 1F7, 1B10, 1H5, 1H9 and 1B5). Our findings suggest that immunization does not necessarily lead to generation of antibodies with high solubility in pharmaceutically relevant formulation conditions, as observed previously (Liu et al., 2005; Nishi et al., 2010 Nishi et al., , 2011 Mason et al., 2011; Sule et al., 2011 Sule et al., , 2012 . Assuming that the AC-SINS analysis of the unpurified mAbs (Fig. 5) is reflective of their solubility, our findings suggest that approximately one-third of the mAbs generated via immunization may be poorly soluble at low ionic strength.
The methodology described in this report demonstrates utility in early discovery, but it will likely also be valuable when applied later in therapeutic antibody development, after a lead molecule is identified with the desired biological properties. If the most efficacious molecule has undesirable physical properties, AC-SINS can be used to guide protein engineering of a more suitable drug for development. Even single residue changes can have a profound impact on properties such as solubility, phase separation and viscosity (Nieba et al., 1997; Tanha et al., 2006; Chennamsetty et al., 2009; Conley et al., 2011; Perchiacca et al., 2011 Perchiacca et al., , 2014 Yadav et al., 2011; Yoshino et al., 2011; Bethea et al., 2012; Dudgeon et al., 2012; Kim et al., 2012; Chaudhri et al., 2013; Kim et al., 2014; Nichols et al., 2015; Sormanni et al., 2015) . Here we demonstrated that a single mutation (W100aA) that significantly increases the solubility and reduces the viscosity of CNTO607 Bethea et al., 2012) could be readily identified in a high-throughput system with unpurified mAbs expressed from 96-well transient transfections. AC-SINS is also compatible with automation given that it is performed in 96-or 384-well plates. Using this methodology to screen unpurified antibody variants, AC-SINS can be leveraged to readily screen tens of thousands of antibody variants for improved solubility in parallel with functional assays.
Conclusion
Our findings demonstrate that AC-SINS enables unusually early assessment of the self-association propensities of mAbs. To our knowledge this is the first demonstration that biophysical measurements of unpurified mAbs can be used to guide the selection of new antibodies with high solubility. Future work will need to evaluate whether this assay is compatible with non-standard antibody formats such as bispecific antibodies and antibody fragments. Additional work is also needed to determine whether AC-SINS can be used to identify mAbs with low viscosity at high concentration based on our encouraging findings for wild-type and mutant versions of CNTO607. We expect that the strengths of AC-SINS-namely its throughput as well as its use of dilute and unpurified mAbs-will enable improved selection of mAb candidates with excellent biophysical properties early in antibody discovery.
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